These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 3274455

  • 1. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract] [Full Text] [Related]

  • 2. Triple immunosuppressive therapy in immunologic high-risk renal allograft recipients.
    Cole E, Robinson C, Bear R.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2026-7. PubMed ID: 2652662
    [No Abstract] [Full Text] [Related]

  • 3. A comparison of three immunosuppressive protocols in patients aged over 50 years.
    Fryd DS, So SK, Kruse L, Canafax DM, Sutherland DE, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1530-1. PubMed ID: 3274374
    [No Abstract] [Full Text] [Related]

  • 4. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
    Stratta RJ, D'Alessandro AM, Armbrust MJ, Pirsch JD, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
    [No Abstract] [Full Text] [Related]

  • 5. Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.
    Gaber AO, Thistlethwaite JR, Haag BW, Stuart J, Mayes J, Fellner S, Stuart FP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1915-6. PubMed ID: 3274451
    [No Abstract] [Full Text] [Related]

  • 6. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
    Halloran P, Ludwin D, Bear R, Aprile M, McQuarrie B, Poole R, White N.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
    [No Abstract] [Full Text] [Related]

  • 7. Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function.
    Woodle ES, Heffron TG, Stuart JK, Thistlethwaite JR, Stuart FP.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1641-2. PubMed ID: 2652536
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract] [Full Text] [Related]

  • 10. Renal transplantation with cyclosporine in the elderly population.
    Velez RL, Brinker KR, Vergne-Marini PJ, Nesser DA, Long DL, Trevino G, Dickerman RM, Helfrich GB.
    Transplant Proc; 1991 Apr; 23(2):1749-52. PubMed ID: 1905073
    [No Abstract] [Full Text] [Related]

  • 11. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ, Harding ME, deVeber GA, Honey J, Cook GT.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P, Squifflet JP, Pirson Y, Stoffel M, Dereme T, Alexandre GP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression.
    Sutherland DE, Fryd DS, Strand M, Ascher N, Simmons RL, Najarian JS.
    Transplant Proc; 1984 Jun; 16(3):629-32. PubMed ID: 6375030
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of OKT3 in kidney, pancreas, and liver transplantation.
    D'Alessandro AM, Pirsch JD, Melzer JS, Sollinger HW, Kalayoglu M, Reed A, Knechtle SJ, Belzer FO.
    Transplant Proc; 1990 Aug; 22(4):1748-9. PubMed ID: 2117796
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Management of immunosuppressive problems in renal allograft recipients.
    Lorber MI, Flechner SM, Van Buren CT, Sorensen K, Kerman RH, Kahan BD.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1951-4. PubMed ID: 3547899
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.